Epi-Cure Consulting Ltd provides specialist expert advice to the Pharmaceutical, Biotech and Venture Capital industries across the full drug product lifecycle, from discovery through commercialisation, and supply chain. The services are focussed on Quality, Development, Regulatory and Due Diligence and the scope covers classical small synthetic molecules through recombinant proteins to genetically modified therapeutic vaccines.